Keith W. Schmidt
Keine laufenden Positionen mehr
Profil
Keith W.
Schmidt served as Vice President at Syntex Laboratories, Inc. and Hoffmann-La Roche, Inc. He was also the Vice President of Sales & Marketing at Chelsea Therapeutics International Ltd.
from 2006 to 2012 and later became the Chief Commercial Officer in 2014.
Schmidt was the President of Tellico Pharma LLC and Vice President at Thomson Healthcare Advanced Therapeutics Communications.
He also served as the Chief Commercial Officer at Ballantyne Therapeutics, Inc. Schmidt earned an undergraduate degree from South Dakota State University and an MBA from the University of San Francisco.
Ehemalige bekannte Positionen von Keith W. Schmidt
| Unternehmen | Position | Ende |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.06.2020 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Corporate Officer/Principal | 23.06.2014 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Vertrieb & Marketing | 10.07.2012 |
| Thomson Healthcare Advanced Therapeutics Communications | Corporate Officer/Principal | 01.05.2005 |
Ballantyne Therapeutics, Inc.
 Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Corporate Officer/Principal | - |
Ausbildung von Keith W. Schmidt
| South Dakota State University | Undergraduate Degree |
| University of San Francisco | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Syntex Laboratories, Inc. | |
| Tellico Pharma LLC | |
| Thomson Healthcare Advanced Therapeutics Communications | |
Ballantyne Therapeutics, Inc.
Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Health Technology |
